Formation of osteolytic lesions in mice given injections of neuroblastoma cells
| Cell line . | Route of injection . | . | |
|---|---|---|---|
| . | Femoral bone marrow, n (%) . | Intravenous, n (%) . | |
| CHLA-255 | 46 (100) | 10 (80) | |
| CHLA-171 | ND | 5 (20) | |
| NB19 | ND | 6 (33) | |
| SK-N-BE(2) | 8 (100) | 11 (55) | |
| SMS-SAN | 8 (100) | ND | |
| Cell line . | Route of injection . | . | |
|---|---|---|---|
| . | Femoral bone marrow, n (%) . | Intravenous, n (%) . | |
| CHLA-255 | 46 (100) | 10 (80) | |
| CHLA-171 | ND | 5 (20) | |
| NB19 | ND | 6 (33) | |
| SK-N-BE(2) | 8 (100) | 11 (55) | |
| SMS-SAN | 8 (100) | ND | |
NOTE: Number of mice given injections (percentage of mice with osteolytic lesions).
Abbreviation: ND, no data.